Skip to main content

High-risk twin pregnancy: case report of an adolescent patient with cystic fibrosis and systemic lupus erythematosus



We present the first case to our knowledge of a spontaneous twin pregnancy in a 16-year-old Caucasian patient with cystic fibrosis and systemic lupus erythematosus. Cystic fibrosis is one of the most common autosomal recessive genetic disorders and primarily affects the respiratory and digestive systems. Systemic lupus erythematosus is a chronic inflammatory disease of unknown cause that affects nearly every organ. Patients with cystic fibrosis or systemic lupus erythematosus are progressively having longer life expectancy and better quality of life, which has led a greater number of female patients reporting the desire to become mothers.

Case presentation

We present a case of a Caucasian 16-year-old pregnant with twins being treated for both cystic fibrosis and systemic lupus erythematosus. She has two CFTR mutations: p.F508del and 1812_1G>A. In the second trimester, she was admitted for possible preterm labor, which was successfully stopped. The patient’s nutritional status worsened, and she had a pulmonary exacerbation as well as a flare of systemic lupus erythematosus. At the 28th gestational week, she presented with a massive hemoptysis episode. The cesarean delivery had no complications, and there were no serious immediate postpartum complications.

Discussion and conclusions

While adolescent pregnancies in and of themselves are considered high risk for both the young mothers and their children, they are further complicated when the mother has two chronic diseases and a twin pregnancy. We achieved positive results using a multidisciplinary approach; however, the risks involved were so high that major efforts are to be taken by our medical community to prevent unplanned pregnancies in all patients with cystic fibrosis, especially when a serious comorbidity like the one in this case is present.

Peer Review reports


The latest Brazilian cystic fibrosis (CF) registry (2016) reported that 3.6% of adult female patients with cystic fibrosis become pregnant. In the same period, the Cystic Fibrosis Foundation Patient Registry (CFFPR) reported a rate of approximately four live births per 100 women who are of reproductive age with CF in the USA. Pregnancy in patients with CF requires continuous monitoring and treatment to maintain maternal pulmonary function and the added nutritional needs of gestation. Furthermore, it requires avoiding, when possible, the use of teratogenic medications in the treatment of pulmonary infections.

Systemic lupus erythematosus (SLE) is a chronic inflammatory disease of unknown cause that affects almost every organ. Cystic fibrosis is also an inflammatory disease, and studies suggest that the presence of inflammation in CF airways is independent of previous infection [1]. As with CF, a better understanding of the pathophysiology of SLE and the involvement of a multidisciplinary team over the last few decades led to an improvement of feto-maternal outcomes. Pregnancy can be associated with flares in patients with SLE [2].

Twin and teenage pregnancy are both independent risk factors for adverse pregnancy outcomes [3].

We present the first case to our knowledge of a spontaneous twin pregnancy in a 16-year-old Caucasian patient with cystic fibrosis and SLE.

Case presentation

The 16-year-old Caucasian patient presented here has CF and is followed regularly at our CF clinic. She has two identified CFTR mutations: p.F508del and 1812_1G>A. She has also been seen by our hospital’s rheumatology team since she was diagnosed with SLE with hematologic activity in September 2016. On that occasion, she presented with thrombocytopenia, antinuclear antibody (ANA) 1:160 with speckled pattern, low c4 measure, Coombs test with agglutination intensity 3 out of 4 and intermittent arthralgia.

During a hospital admission for a pulmonary exacerbation in August 2017, she was treated with intravenous antibiotics and methotrexate was momentarily discontinued. Prior to resuming methotrexate, a known teratogenic drug, a pregnancy blood test (β-human chorionic gonadotropin) was conducted.

A pregnancy was then detected, and she was placed on prenatal follow-up with the obstetrics team. A first-trimester ultrasonography showed that she had a monochorionic and diamniotic twin pregnancy. The patient was also treated for syphilis during her first trimester [Venereal Disease Research Laboratory (VDRL) 1:4 on 18 September 2017]. In the second trimester, she was admitted for possible preterm labor, which was successfully stopped. However, the patient’s nutritional status worsened, and she had a pulmonary exacerbation. Intravenous antibiotics (ceftazidime and oxacillin) were then initiated on the basis of her sputum cultures and safety profile concerning teratogenic risks. She also presented a SLE flare with thrombocytopenia and was treated with corticosteroids with a good response.

During pregnancy, a worsening in her lung function was observed. Her lung function prior to gestation showed an obstructive ventilatory pattern with a forced vital capacity (FVC) 110% and first second of forced expiratory volume (FEV1) 76% of predicted.

Since admission during her second trimester, she struggled to gain weight. To improve her nutritional status, additional enteral feeding was started, and the patient had slow but progressive weight gain. At the 28th gestational week, she presented a massive hemoptysis episode. A bronchial artery embolization was then indicated. However, considering the radiation exposure involved in the procedure and the associated risk for the patient and the fetuses, a cesarean section was conducted beforehand (Fig. 1).

Fig. 1
figure 1

Embolization of right bronchial artery with abnormal contrast impregnation of pulmonary parenchyma

The cesarean delivery in late January 2018 had no complications. The first-born baby weighed 880 g with an Apgar score of 1 and 8, and the second baby weighed 980 g with an Apgar score of 3 and 7, both being admitted to neonatal intensive care unit (ICU). They needed mechanical ventilation for at least their first month of life. The firstborn was soon diagnosed with ventricular septal defect and was managed with diuretics while awaiting surgical correction. The second baby needed supplemental oxygen but was slowly and successfully weaned off.

Our patient had no serious immediate postpartum complications. Both babies were discharged from the pediatric ward and are doing well at home so far. Our patient, however, has had several exacerbations since her delivery, mostly due to her lack of adherence to CF treatment. She also struggled with depression after birth and is now medicated and doing better in this regard.

Discussion and conclusions

In the past few years, the life expectancy and quality of life of patients with cystic fibrosis have improved. This has led to increasing numbers of reports of female patients wishing to become mothers. In our pediatric service, this was the first pregnant adolescent patient. As discussed by Jessup et al., the growing number of parents with cystic fibrosis has implications not only for them, who already have the burden of CF care, but also for their children’s risk of premature death [4]. Tonelli et al. suggested that psychological support for mothers with CF and their children ought to be provided to decrease the incidence of depression, guilt, self-criticism, and lack of self-confidence [5]. Our patient suffered from postpartum depression, including suicidal ideation, and responded well to psychiatric support. Our patient’s treatment adherence was not optimal before or during her pregnancy. It was clear that, especially in the first months, her CF treatment was neglected. Authors from a large single-center study in the USA recommended aggressive management for all pregnant women with cystic fibrosis, including the use of parenteral nutrition to maintain adequate weight gain [6]. The nutritional status of this patient was another challenge, since she was losing weight during the second trimester of pregnancy, and as a result she remained hospitalized to receive adequate treatment. Financial costs and patient burden are often high during pregnancy in patients with cystic fibrosis, including the high number of prenatal visits (mean 12), days on intravenous antibiotics (mean 30 days), and total hospitalization days, both pre- and postpartum (mean 25 days) [6].

During pregnancy in patients with CF, lung function can worsen because of increased abdominal growth, minute ventilation, and oxygen demand [7]. Gestational diabetes mellitus and presence of cardiovascular risk factors can also worsen the prognosis of patients with cystic fibrosis and systemic lupus erythematosus [8, 9].

The treatment of pulmonary exacerbations in this case was also a challenge encompassing the selection of adequate safe antibiotic regimens for pregnant women in addition to the management of hemoptysis. Even though there is a growing number of studies evaluating the safety of these drugs during pregnancy, this topic is still rarely discussed in the literature. In this case, adequate treatment based on the sputum bacteriological profile was only possible after labor [10]. The interruption of her pregnancy at 28 weeks due to a massive hemoptysis was also part of this challenge.

Regarding the outcomes in pregnancies of patients with CF, Gilljam et al., in a single-center study from Toronto, found no long-term detrimental effects in women with cystic fibrosis who had children. Goss et al., using the large national US Cystic Fibrosis Foundation Registry, confirmed and expanded upon this finding [11, 12]. Another American paper, by Schechter et al. in 2013, showed that neither pregnancy nor motherhood appeared to accelerate disease progression, although pregnancy and motherhood does lead to more illness-related visits, pulmonary exacerbations, and a decrease in some domains of quality of life. They speculated that these differences may be due to the impact of the physical and emotional challenges of early motherhood on disease self-management [13], which is in accordance with our patient´s status today.

Increased mucus clogging and lung injury in CF, some studies showed, are associated with neutrophil cytotoxins, extracellular DNA, and neutrophil extracellular traps (NETs). Dysregulated NET formation or clearance has been associated with CF and chronic inflammatory and autoimmune disorders [14].

Considering the rheumatologic aspects in a patient with SLE, the maternal fetal outcomes have improved in the last decades. Khan et al. highlight the importance of a multidisciplinary team to minimize complications [2]. The flare rates during pregnancy of women with SLE vary in the literature from 25% to 65% [15,16,17,18,19]. Khan et al. showed that the majority of SLE flares were mild to moderate. The patient presented with thrombocytopenia since her SLE diagnosis, and this persisted during pregnancy, as the flares were well managed solely with corticosteroids. Other complications related to SLE during pregnancy, such as preeclampsia, maternal death, and spontaneous abortion, did not occur in this case [20, 21].

In a Brazilian cohort, 14 out of 24 young pregnant SLE women were still followed by a pediatrician. In this same study, 21% of the patients had disease activity during their pregnancy, similar to the patient reported here. They found that less than 10% had mild flares after the onset of pregnancy and responded to temporary increase in corticosteroid dosage [21].

Sexual behavior of teenagers with chronic diseases does not differ from that of other teenagers. It is important to provide advice on contraception and prevention of sexually transmitted diseases (STD) during follow-up [20].

Considering the complexity of this case, in which multiple comorbidities conspired to bring about an unfavorable outcome, our success was unexpected when we consider that both twins, although prematurely delivered, survived without major complications and the mother had an uneventful post-delivery outcome. These positive results came as a consequence of a multidisciplinary approach; however, the risks involved were so high that major efforts are to be taken by our medical community to prevent unplanned pregnancies in all patients with CF, especially when a serious comorbidity like the one in this case is present.

In Table 1, the comorbidities our patient presented during pregnancy are shown in bold.

Table 1 Risks described in the literature for each comorbidity

Availability of data and materials

The patient’s data available in this paper are in the patient’s records in Hospital de Clínicas de Porto Alegre.



Cystic fibrosis


Systemic lupus erythematosus


Cystic Fibrosis Foundation Patient Registry


Antinuclear antibody


Venereal Disease Research Laboratory


Forced vital capacity


First second of forced expiratory volume


Intensive care unit


Neutrophil extracellular traps


  1. Verhaeghe C, Delbecque K, de Leval L, Oury C, Bours V. Early inflammation in the airways of a cystic fibrosis foetus. J Cyst Fibros. 2007;6(4):304–8.

    CAS  Article  Google Scholar 

  2. Khan A, Thomas M, Symala Devi PK. Pregnancy complicated by systemic lupus erythematosus and its outcome over 10 years. J Obstet Gynaecol. 2018;38(4):476–81.

    Article  Google Scholar 

  3. McLennan AS, Gyamfi-Bannerman C, Ananth CV, Wright JD, Siddiq Z, D’Alton ME, et al. The role of maternal age in twin pregnancy outcomes. Am J Obstet Gynecol. 2017;217(1):80.e1-80.e8.

    Article  Google Scholar 

  4. Jessup M, Li A, Fulbrook P, Bell SC. The experience of men and women with cystic fibrosis who have become a parent: a qualitative study. J Clin Nurs. 2018;27(7–8):1702–12.

    Article  Google Scholar 

  5. Tonelli MR, Aitken ML. Pregnancy in cystic fibrosis. Curr Opin Pulm Med. 2007;13(6):537–40.

    Article  Google Scholar 

  6. Cheng EY, Goss CH, McKone EF, Galic V, Debley CK, Tonelli MR, et al. Aggressive prenatal care results in successful fetal outcomes in CF women. J Cyst Fibros. 2006;5(2):85–91.

    Article  Google Scholar 

  7. Ahluwalia M, Hoag JB, Hadeh A, Ferrin M, Hadjiliadis D. Cystic fibrosis and pregnancy in the modern era: a case control study. J Cyst Fibros. 2014;13(1):69–73.

    Article  Google Scholar 

  8. Jelin AC, Sharshiner R, Caughey AB. Maternal co-morbidities and neonatal outcomes associated with cystic fibrosis. J Matern Fetal Neonatal Med. 2017;30(1):4–7.

    Article  PubMed  Google Scholar 

  9. Tselios K, Urowitz MB. Cardiovascular and pulmonary manifestations of systemic lupus erythematosus. Curr Rheumatol Rev. 2017;13(3):206–18.

    Article  PubMed  Google Scholar 

  10. Kroon MAGM, Akkerman-Nijland AM, Rottier BL, Koppelman GH, Akkerman OW, Touw DJ. Drugs during pregnancy and breast feeding in women diagnosed with cystic fibrosis—an update. J Cyst Fibros. 2018;17(1):17–25.

    CAS  Article  Google Scholar 

  11. Gilljam M, Antoniou M, Shin J, Dupuis A, Corey M, Tullis DE. Pregnancy in cystic fibrosis. Fetal and maternal outcome. Chest. 2000;118(1):85–91.

    CAS  Article  Google Scholar 

  12. Goss CH, Rubenfeld GD, Otto K, Aitken ML. The effect of pregnancy on survival in women with cystic fibrosis. Chest. 2003;124(4):1460–8.

    Article  Google Scholar 

  13. Schechter MS, Quittner AL, Konstan MW, Millar SJ, Pasta DJ, McMullen A, et al. Long-term effects of pregnancy and motherhood on disease outcomes of women with cystic fibrosis. Ann Am Thorac Soc. 2013;10(3):213–9.

    Article  Google Scholar 

  14. Khan MA, Ali ZS, Sweezey N, Grasemann H, Palaniyar N. Progression of cystic fibrosis lung disease from childhood to adulthood: neutrophils, neutrophil extracellular trap (NET) formation, and NET degradation. Genes. 2019.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Petri M, Genovese M, Engle E, Hochberg M. Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study. Arthritis Rheum. 1991;34(8):937–44.

    CAS  Article  Google Scholar 

  16. Ruiz-Irastorza G, Lima F, Alves J, Khamashta MA, Simpson J, Hughes GR, et al. Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies. Br J Rheumatol. 1996;35(2):133–8.

    CAS  Article  Google Scholar 

  17. Cortés-Hernández J, Ordi-Ros J, Paredes F, Casellas M, Castillo F, Vilardell-Tarres M. Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies. Rheumatology. 2002;41(6):643–50.

    Article  Google Scholar 

  18. Imbasciati E, Tincani A, Gregorini G, Doria A, Moroni G, Cabiddu G, et al. Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome. Nephrol Dial Transplant. 2009;24(2):519–25.

    Article  Google Scholar 

  19. Carvalheiras G, Vita P, Marta S, Trovão R, Farinha F, Braga J, et al. Pregnancy and systemic lupus erythematosus: review of clinical features and outcome of 51 pregnancies at a single institution. Clin Rev Allergy Immunol. 2010;38(2–3):302–6.

    Article  Google Scholar 

  20. Ling N, Lawson E, von Scheven E. Adverse pregnancy outcomes in adolescents and young women with systemic lupus erythematosus: a national estimate. Pediatr Rheumatol Online J. 2018.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Silva CA, Hilario MO, Febronio MV, et al. Pregnancy outcome in juvenile systemic lupus erythematosus: a Brazilian multicenter cohort study. J Rheumatol. 2008;35(7):1414–8.

    PubMed  Google Scholar 

Download references


We would like to acknowledge everybody on the CF multidisciplinary team of Hospital de Clínicas de Porto Alegre, the rheumatology team, the gynecology team, and the neonatologist as well as the radiologist team. Without their hard work, this patient outcome would have been possible.


No funding was obtained.

Author information

Authors and Affiliations



All authors have contributed in the process of writing and reviewing this paper. PBS gathered all data for this paper and was deeply involved in the writing process. AH was the attending physician for this patient since her arrival in the CF team and analyzed all data regarding CF. MSF contributed to the review of CF data and the manuscript. MTVS and MSM analyzed all data regarding genetics. SM was involved in the rheumatologic care and analyzed the respective data. PJCM was involved in the analysis of CF data and reviewed the final manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Paula Baptista Sanseverino.

Ethics declarations

Ethics approval and consent to participate

This case report was approved by the ethics committee of Hospital de Clínicas de Porto Alegre da Universidade Federal do Rio Grande do Sul-HCPA (CAAE: 91638818.6.0000.5327) as part of a masters project on CF. The patient provided consent to participate in this project.

Consent for publication

Written informed consent was obtained from the patient and the patient’s parent for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

Competing interests

There are no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Sanseverino, P.B., Hoffmann, A., Machado, S. et al. High-risk twin pregnancy: case report of an adolescent patient with cystic fibrosis and systemic lupus erythematosus. J Med Case Reports 16, 230 (2022).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI:


  • Cystic fibrosis
  • Systemic lupus erythematosus
  • Adolescent pregnancy
  • Multiple pregnancy